Bioactive Macrocyclic Natural Products

Heterocycles in Natural Product Synthesis

Volumn , Issue , 2011, Pages 569-619

  Mohd Nor, Siti Mariam ^a   Xu, Zhengshuang ^b,c   Ye, Tao ^b,c  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b PEKING UNIVERSITY   (China)

^c HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

Azoles; Furan; Heterocycles; Imidazole; Indole; Medium and large ring sized; Natural products; Pyran; Synthesis

Indexed keywords

SPEECH SYNTHESIS; SYNTHESIS (CHEMICAL);

AZOLES; FURAN; HETEROCYCLES; IMIDAZOLE; INDOLE; LARGE RINGS; NATURAL PRODUCTS; PYRAN;

CHEMISTRY;

EID: 84873875834     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527634880.ch16     Document Type: Chapter

References (173)

1. Buss, A.D. and Butler, M.S. (2010) Natural product chemistry for drug discovery (RSC Biomolecular Sciences No. 18). J. Med. Chem., 53, 2329-2329
2. Li, J.W.- H. and Vederas, J.C. (2009) Drug discovery and natural products: end of an era or an endless frontier? Science, 325, 161-165
3. Butler, M.S. (2008) Natural products to drugs: natural product-derived compounds in clinical trials. Nat. Prod. Rep., 25, 475-516
4. Hughes, B. (2009) 2008 FDA drug approvals. Nat. Rev. Drug Discov., 8, 93-96
5. Rosen, J., Gottfries, J., Muresan, S., Backlund, A. and Oprea, T.I. (2009) Novel chemical space exploration via natural products. J. Med. Chem., 52, 1953-1962
6. Chin, Y.-W., Balunas, M.J., Chai, H.B. and Kinghorn, A.D. (2006) Drug discovery from natural sources. AAPS J., 8, 239-253
7. (g) Butler, M.S. (2004) The role of natural product chemistry in drug discovery. J. Nat. Prod., 67, 2141-2153
8. Balunas, M.J. and Kinghorn, A.D. (2005) Drug discovery from medicinal plants. Life Sci., 78, 431-441.
9. Luesch, H., Yoshida, W.Y., Moore, R.E., Paul, V.J. and Corbett, T.H. (2001) Total structure determination of apratoxin A, a potent novel cytotoxin from the marine cyanobacterium Lyngbya majuscula. J. Am. Chem. Soc., 123, 5418-5423
10. Luesch, H., Yoshida, W.Y., Moore, R.E., Paul, V.J. and Corbett, T.H. (2002) New apratoxins of marine cyanobacterial origin from Guam and Palau. Bioorg. Med. Chem., 10, 1973-1978.
11. Luesch, H., Chanda, S.K., Raya, R.M., Dejesus, P.D., Orth, A.P., Walker, J.R., Belmonte, J.C.I. and Schultz, P.G. (2006) A functional genomics approach to the mode of action of the antiproliferative natural product apratoxin A. Nat. Chem. Biol., 2, 158-167.
12. Chen, J. and Forsyth, C.J. (2003) Total synthesis of apratoxin A. J. Am. Chem. Soc., 125, 8734-8735
13. Chen, J. and Forsyth, C.J. (2004) Total synthesis of the marine cyanobacterial cyclodepsipeptide apratoxin A. Proc. Natl. Acad. Sci. U.S.A., 101, 12067-12072.
14. Ma, D., Zou, B., Cai, G., Hu, X. and Liu, J.O. (2006) Total synthesis of the cyclodepsipeptide apratoxin A and its analogs and assessment of their biological activities. Chem. Eur. J., 12, 7615-7626
15. Doi, T., Numajiri, Y., Munakata, A. and Takahashi, T. (2006) Total synthesis of apratoxin A. Org. Lett., 8, 531-534
16. Numajiri, Y., Takahashi, T. and Doi, T. (2009) Total synthesis of (-)-apratoxin A, 34-epimer, and its oxazoline analog. Chem. Asian J., 4, 111-125.
17. Randazzo, A., Bifulco, G., Giannini, C., Bucci, M., Debitus, C., Cirino, G. and Gomez-Paloma L. (2001) Halipeptins A and B: two novel potent anti -inflammatory cyclic depsipeptides from the Vanuatu marine sponge Haliclona species. J. Am. Chem. Soc., 123, 10870-10876.
18. Della Monica C., A. Randazzo, G. Bifulco, P. Cimino, M. Aquino, I. Izzo, F. De Riccardis F. and Gomez-Paloma L. (2002) Structural revision of halipeptins: synthesis of the thiazoline unit and isolation of halipeptin C. Tetrahedron Lett., 43, 5707-5710.
19. Nicolaou, K.C., Schlawe, D., Kim, D., Longbottom, D.A., de Noronha, R.G., Lizos, D.E., Rao Manam, R. and Faulkner, D.J. (2005) Total synthesis of halipeptins: isolation of halipeptin D and synthesis of oxazoline halipeptin analogs. Chem. Eur. J., 11, 6197-6211.
20. Nicolaou, K.C., Kim, D.W., Schlawe, D., Lizos, D.E., de Noronha, R.G. and Longbottom, D.A. (2005) Total synthesis of halipeptins A and D and analogs. Angew. Chem. Int. Ed., 44, 4925-4929
21. Nicolaou, K.C., Lizos, D.E., Kim, D.W., Schlawe, D., de Noronha, R.G., Longbottom, D.A., Rodriquez, M., Bucci, M. and Cirino, G. (2006) Total synthesis and biological evaluation of halipeptins A and D and analogs. J. Am. Chem. Soc., 128, 4460-4470.
22. Yu, S., Pan, X., Lin, X. and Ma, D. (2005) Total synthesis of halipeptin A, a potent anti-inflammatory cyclic depsipeptide. Angew. Chem. Int. Ed., 44, 135-138.
23. Hara, S., Makino, K. and Hamada, Y. (2006) Total synthesis of halipeptin A, a potent anti-inflammatory cyclodepsipeptide from a marine sponge. Tetrahedron Lett., 47, 1081-1085.
24. Taori, K., Paul, V.J. and Luesch, H. (2008) Structure and activity of largazole, a potent antiproliferative agent from the floridian marine cyanobacterium Symploca sp. J. Am. Chem. Soc., 130, 1806-1807
25. Ying, Y., Taori, K., Kim, H., Hong, J. and Luesch, H. (2008) Total synthesis and molecular target of largazole, a histone deacetylase inhibitor. J. Am. Chem. Soc., 130, 8455-8459.
26. Masuoka, Y., Nagai, A., Shin-Ya, K., Furihata, K., Nagai, K., Suzuki, K., Hayakawa, Y. and Seto, H. (2001) Spiruchostatins A and B, novel gene expression-enhancing substances produced by Pseudomonas sp. Tetrahedron Lett., 42, 41-44
27. Shigematsu, N., Ueda, H., Takase, S. and Taneka, H. (1994) FR901228, a novel antitumor bicyclic depsipeptide produced by chromobacterium Violaceum no. 968. II. Structure determination. J. Antibiot., 47, 311-314
28. Yoshida, M., Kijama, M., Akita, M. and Beppu, T. (1990) Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem., 265, 17174-17179
29. Bowers, A., West, N., Taunton, J., Schreiber, S.L., Bradner, J.E. and Williams, R.M. (2008) Total synthesis and biological mode of action of largazole: a potent class I histone deacetylase inhibitor. J. Am. Chem. Soc., 130, 11219-11222
30. Yurek-George, A., Cecil, A.R.L., Mo, A.H.K., Wen, S., Rogers, H., Habens, F., Maeda, S., Yoshida, M., Packham, G. and Ganesan, A. (2007) The first biologically active synthetic analogs of FK228, the depsipeptide histone deacetylase inhibitor. J. Med. Chem., 50, 5720-5726
31. Greshock, T.J., Johns, D.M., Noguchi, Y. and Williams, R.M. (2008) Improved total synthesis of the potent HDAC inhibitor FK228 (FR-901228). Org. Lett., 10, 613-616.
32. Seiser, T., Kamena, F. and Cramer, N. (2008) Synthesis and biological activity of largazole and derivatives. Angew. Chem. Int. Ed., 47, 6483-6485.
33. Ren, Q., Dai, L., Zhang, H., Tan, W., Xu, Z. and Ye, T. (2008) Total synthesis of largazole. S ynlett, 2379-2383.
34. Numajiri, Y., Takahashi, T., Takagi, M., Shin-ya, K. and Doi, T. (2008) Total synthesis of largazole and its biological evaluation. S ynlett, (16), 2483-2486.
35. Nasveschuk, C.G., Ungermannova, D., Liu, X. and Phillips, A.J. (2008) A concise total synthesis of largazole, solution structure, and some preliminary structure activity relationships. Org. Lett., 10, 3595-3598.
36. Ghosh, A.K. and Kulkarni, S. (2008) Enantioselective total synthesis of (+)-largazole, a potent inhibitor of histone deacetylase. O rg. Lett., 10, 3907-3909.
37. Wang, B. and Forsyth, C.J. (2009) Total synthesis of largazole-devolution of a novel synthetic strategy. Synthesis, 2873-2880.
38. Zeng, X., Yin, B., Hu, Z., Liao, C., Liu, J., Li, S., Li, Z., Nicklaus, M.C., Zhou, G. and Jiang, S. (2010) Total synthesis and biological evaluation of largazole and derivatives with promising selectivity for cancers cells. Org. Lett., 12, 1368-1371.
39. Bowers, A.A., West, N., Newkirk, T.L., Troutman-Youngman, A.E., Schreiber, S.L., Wiest, O., Bradner, J.E. and Williams, R.M. (2009) Synthesis and histone deacetylase inhibitory activity of largazole analogs: alteration of the zinc-binding domain and macrocyclic scaffold. Org. Lett., 11, 1301-1304
40. Bowers, A.A., Greshock, T.J., West, N., Estiu, G., Schreiber, S.L., Wiest, O., Williams, R.M. and Bradner, J.E. (2009) Synthesis and conformation - activity relationships of the peptide isosteres of FK228 and largazole. J. Am. Chem. Soc., 131, 2900-2905
41. Ying, Y., Liu, Y., Byeon, S.R., Kim, H., Luesch, H. and Hong, J. (2008) Synthesis and activity of largazole analogs with linker and macrocycle modification. Org. Lett., 10, 4021-4024
42. Chen, F., Gao, A.-H., Li, J. and Nan, F.-J. (2009) Synthesis and biological evaluation of C7-demethyl largazole analogs. Chem. Med. Chem., 4, 1269-1272.
43. Perez, L.J. and Faulkner, D.J. (2003) Bistratamides E-J, modified cyclic hexapeptides from the Philippines ascidian Lissoclinum bistratum. J. Nat. Prod., 66, 247-250.
44. Hawkins, C.J., Watters, D.J., Lavin, M.F., Parry, D.L. and McCaffrey, E.J. (1990) WO 9005731 A1.
45. Rudi, A., Chill, L., Aknin, M. and Kasman, Y. (2003) Didmolamide A and B, two new cyclic hexapeptides from the marine ascidian Didemnum molle. J. Nat. Prod., 66, 575-577.
46. You, S.L. and Kelly, J.W. (2004) Highly efficient biomimetic total synthesis and structural verification of bistratamides E and J from Lissoclinum bistratum. Chem. Eur. J., 10, 71-75
47. You, S.L. and Kelly, J.W. (2005) The total synthesis of bistratamides F-I. Tetrahedron, 61, 241-249.
48. Bertram, A., Maulucci, N., New, O.M., Mohd Nor, S.M. and Pattenden, G. (2007) Synthesis of libraries of thiazole, oxazole and imidazole-based cyclic peptides from azole-based amino acids. A new synthetic approach to bistratamides and didmolamides. Org. Biomol. Chem., 5, 1541-1553.
49. Bertram, A. and Pattenden, G. (2000) Self-assembly of amino acid-based thiazoles and oxazoles. Total synthesis of dendroamide A, a cyclic hexapeptide from the cyanobacterium Stigonema dendroideum. Synlett, 1519-1521
50. Bertram, A. and Pattenden, G. (2002) Dendroamide A, nostocyclamide and related cyclopeptides from cyanobacteria. Total synthesis, together with organised and metal-templated assembly from oxazole and thiazole-based amino acids. Heterocycles, 58, 521-561
51. Bertram, A. and Pattenden, G. (2001) Synthesis and metal-templated assembly of oxazole and thiazole-based amino acids. Total synthesis of nostocyclamide and related cyclic peptides. Synlett, 1873-1874.
52. Romero, F., Malet, L., Cañedo, M.L., Cuevas, C. and Reyes, J. (2005) WO 2005000880 A2.
53. Kanoh, K., Matsuo, Y., Adachi, K., Imagawa, H., Nishizawa, M. and Shizuri, Y. (2005) Mechercharmycins A and B, cytotoxic substances from marine-derived Thermoactinomyces sp. YM3-251. J. Antibiot., 58, 289-292.
54. Hernández, D., Vilar, G., Riego, E., Cañedo, M.L., Cuevas, C., Albericio, F. and Alvarez, M. (2007) Synthesis of IB-01211, a cyclic peptide containing 2,4-concatenated thia-and oxazoles, via Hantzsch macrocyclization. Org. Lett., 9, 809-811.
55. Shin-Ya, K., Wierzba, K., Matsuo, K., Ohtani, T., Yamada, Y., Furihata, K., Hayakawa, Y. and Seto, H. (2001) Telomestatin, a novel telomerase inhibitor from Streptomyces anulatus. J. Am. Chem. Soc., 123, 1262-1263.
56. Shammas, M.A., Reis, R.J.S., Li C., Koley, H., Hurley, L.H., Anderson, K.C. and Munshi N.C. (2004) Telomerase inhibition and cell growth arrest after telomestatin treatment in multiple myeloma. C lin. Cancer Res., 10, 770-776.
57. Yamada, S., Shigeno, K., Kitagawa, K., Okajima, S. and Asao, T. (2002) WO 200248153
58. Deeley, J., Bertram, A. and Pattenden, G. (2008) Novel polyoxazole-based cyclopeptides from Streptomyces sp. Total synthesis of the cyclopeptide YM-216391 and synthetic studies towards telomestatin. Org. Biomol. Chem., 6, 1994-2010
59. Doi, T., Yoshida, M., Shin-Ya, K. and Takahashi, T. (2006) Total synthesis of (R)-telomestatin. Org. Lett., 8, 4165-4167.
60. Endoh, N., Tsuboi, K., Kim, R., Yonezawa, Y. and Shin, C. (2003) Useful synthesis of the longer array oxazole rings for telomestatin. Heterocycles, 60, 1567-1572.
61. You, S., Razavi, H. and Kelly, J.W. (2003) A biomimetic synthesis of thiazolines using hexaphenyl-oxodiphosphonium trifluoromethanesulfonate. Angew. Chem. Int. Ed., 42, 83-85.
62. Anborgh, P.H. and Parmeggiani, A. (1993) Probing the reactivity of the GTP-and GDP-bound conformations of elongation factor Tu in complex with the antibiotic GE2270 A. J. Biol. Chem., 268, 24622-24628
63. Heffron, S.E. and Jurnak, F. (2000) Structure of an EF-Tu complex with a thiazolyl peptide antibiotic determined at 2.35 Å resolution: atomic basis for GE2270A inhibition of EF-Tu. Biochemistry, 39, 37-45
64. Parmeggiani, A., Krab, I.M., Okamura, S., Nielsen, R.C., Nyborg, J. and Nissen, P. (2006) Structural basis of the action of pulvomycin and GE2270 A on elongation factor Tu. Biochemistry, 45, 6846-6857.
65. McConkey, G.A., Rogers, M.J. and McCutchan, T.F. (1997) Inhibition of Plasmodium falciparum protein synthesis targeting the plastid-like organelle with thiostrepton. J. Biol. Chem., 272, 2046-2049.
66. Jonghee, K. (2002) PCT Int. Appl. WO 2002066046
67. Ueno, M., Furukawa, S., Abe, F., Ushioda, M., Fujine, K., Johki, S., Hatori, H. and Ueda, H. (2004) Suppressive effect of antibiotic siomycin on antibody production. J. Antibiot., 57, 590-596.
68. Amythiamicin D: Isolation: Shimanaka, K., Takahashi, Y., Iinuma, H., Naganawa, H. and Takeuchi, T. (1994) Novel antibiotics, amythiamicins. II. Structure elucidation of amythiamicin D. J. Antibiot., 47, 1145-1152
69. Shimanaka, K., Takahashi, Y., Iinuma, H., Naganawa, H. and Takeuchi, T. (1994) Novel antibiotics, amythiamicins. III. Structure elucidations of amythiamicins A, B and C. J. Antibiot., 47, 1153-1159
70. Shimanaka, K., Iinuma, H., Hamada, M., Ikeno, S., Tsuchiya, K.S., Arita, M. and Hori, M. (1995) Novel antibiotics, amythiamicins IV. A mutation in the elongation factor Tu gene in a resistant mutant of B. subtilis. J. Antibiot., 48, 182-184
71. Total synthesis: Hughes, R.A., Thompson, S.P., Alcaraz, L. and Moody, C.J. (2005) Total synthesis of the thiopeptide antibiotic amythiamicin D. J. Am. Chem. Soc., 127, 15644-15651.
72. Thiostrepton: Isolation: Anderson, B., Hodgkin, D.C. and Viswamitra, M.A. (1970) The structure of Thiostrepton. Nature, 225, 233-235
73. Total synthesis: Nicolaou, K.C., Safina, B.S., Zak, M., Estrada, A.A. and Lee, S.H. (2004) Total synthesis of thiostrepton, Part 1: construction of the dehydropiperidine/ thiazoline-containing macrocycle. A ngew. Chem. Int. Ed., 43, 5087-5092
74. Nicolaou, K.C., Zak, M., Safina, B.S., Lee, S.H. and Estrada, A.A. (2004) Total synthesis of thiostrepton, Part 2: construction of the quinaldic acid macrocycle and final stages of the synthesis. A ngew. Chem., Int. Ed., 43, 5092-5097.
75. Siomycin A: Isolation: Nishimura, H., Okamoto, S., Mayama, M., Ohtsuka, H., Nakajima, K., Tawara, K., Shimohira, M. and Shimaoka, N. (1961) Siomycin, a new thiostrepton-like antibiotic. J. Antibiot., 14, 255-263
76. Total synthesis: Mori, T., Higashibayashi, S., Goto, T., Kohno, M., Satouchi, Y., Shinko, K., Suzuki, K., Suzuki, S., Tohmiya, H., Hashimoto, K. and Nakata, M. (2007) Total synthesis of siomycin a. Tetrahedron Lett., 48, 1331-1335
77. Higashibayashi, S., Hashimoto, K. and Nakata, M. (2002) Synthetic studies on the thiostrepton family of peptide antibiotics: synthesis of the tetrasubstituted dehydropiperidine and piperidine cores. Tetrahedron Lett., 43, 105-110.
78. Cyclothiazomycin: Aoki, M., Ohtsuka, T., Yamada, M., Ohba, Y., Yoshizaki, H., Yasuno, H., Sano, T., Watanabe, J., Yokose, K., Seto, H. (1991) Cyclothiazomycin, a novel polythiazole -containing peptide with renin inhibitory activity taxonomy, fermentation, isolation and physico-chemical characterization. J. Antibiot., 44, 582-588.
79. Promothiocins: Isolation: Yun, B.S., Hidaka, T., Furihata, K. and Seto, H. (1994) Promothiocins A and B. novel thiopeptides with a tip a promoter inducing activity produced by Streptomyces sp. SF2741. J. Antibiot., 47, 510-514
80. Total synthesis: Bagley, M.C., Bashford, K.E., Hesketh, C.L. and Moody, C.J. (2000) Total synthesis of the thiopeptide promothiocin A. J. Am. Chem. Soc., 122, 3301-3313
81. Moody, C.J. and Bagley, M.C. (1998) The first synthesis of promothiocin A. Chem. Commun., 2049-2050.
82. Fuller, A.T. (1955) A new antibiotic of bacterial origin. Nature, 175, 722-722.
83. Harms, J.M., Wilson, D.N., Schluenzen, F., Connell, S.R., Stachelhaus, T., Zaborowska, Z., Spahn, C.M.T. and Fucini, P. (2008) Translational regulation via L11: molecular switches on the ribosome turned on and off by thiostrepton and micrococcin. Mol. Cell, 30, 26-38
84. Cundliffe, E. and Thompson, J. (1981) Concerning the mode of action of micrococcin upon bacterial protein synthesis. Eur. J. Biochem., 118, 47-52
85. Rosendahl, G. and Douthwaite, S. (1994) The antibiotics micrococcin and thiostrepton interact directly with 23S rRNA nucleotides 1067A and 1095A. Nucleic Acids Res., 22, 357-363.
86. Su, T.L. (1948) Micrococcin, an antibacterial substance formed by a strain of Micrococcis. Brit. J. Exp. Path., 29, 473-481.
87. Merritt, E.A. and Bagley, M.C. (2007) Convergent synthesis of the central heterocyclic domain of micrococcin P1. Synlett, 954-958
88. Yonezawa, Y., Konn, A. and Shin, C.-G. (2004) Useful synthesis of 2,3,6-tri-and 2,3,5,6-tetrasubstituted pyridine derivatives from aspartic acid. Heterocycles, 63, 2735-2746
89. Okumura, K., Shigekuni, M., Nakamura, Y. and Shin, C.-G. (1996) Useful synthesis of 2,3,6-polythiazolesubstituted pyridine skeleton [fragment A-C] of peptide antibiotic, micrococcin P. Chem. Lett., 1025-1026.
90. Lefranc, D. and Ciufolini, M.A. (2009) Total synthesis and stereochemical assignment of micrococcin P1. Angew. Chem. Int. Ed., 48, 4198-4201.
91. Selva, E., Beretta, G., Montanini, N., Saddler, G.S., Gastaldo, L., Ferrari, P., Lorenzetti, R., Landini, P., Ripamonti, F., Goldstein, B.P., Berti, M., Montanaro, L. and Denaro, M. (1991) Antibiotic Ge2270 A: a novel inhibitor of bacterial protein synthesis. I. Isolation and characterization. J. Antibiot., 44, 693-701
92. Kettenring, J., Colombo, L., Ferrari, P., Tavecchia, P., Nebuloni, M., K. Vekey, Gallo G.G. and Selva, E. (1991) Antibiotic Ge2270 A: a novel inhibitor of bacterial protein synthesis. II. Structure elucidation. J. Antibiot., 44, 702-715
93. Selva, E., Ferrari, P., Kurz, M., Tavecchia, P., Colombo, L., Stella, S., Restelli, E., Goldstein, B.P., Ripamonti, F. and Denaro, M. (1995) Components of the GE2270 complex produced by Planobispom rosea ATCC 53773. J. Antibiot., 48, 1039-1042
94. Total synthesis: Nicolaou, K.C., Zou, B., Dethe, D.H., Li, D.B., Chen, D. and Chen, Y.K. (2006) Total synthesis of antibiotics GE2270A and GE2270T. Angew. Chem. Int. Ed., 45, 7786-7792
95. Delgado, O., Müller, H.M. and Bach, T. (2008) Concise total synthesis of the thiazolyl peptide antibiotic GE2270 A. Chem. Eur. J., 14, 2322-2339.
96. Tavecchia, P., Gentili, P., Kurz, M., Sottani, C., Bonfichi, R., Selva, E., Lociuro, S., Restelli, E. and Ciabatti, R. (1995) Degradation studies of antibiotic MDL 62879 (GE2270A) and revision of the structure. Tetrahedron, 51, 4867-4890
97. Heckmann, G. and Bach, T. (2005) Synthesis of the heterocyclic core of the GE 2270 antibiotics and structure elucidation of a major degradation product. Angew. Chem. Int. Ed., 44, 1199-1201.
98. Muller, H.M., Delgado, O. and Bach, T. (2007) Total synthesis of the thiazolyl peptide GE2270 A. Angew. Chem. Int. Ed., 46, 4771-4774.
99. Kobayashi, J., Suzuki, H., Shimbo, K., Takeya, K. and Morita, H. (2001) Celogentins A-C, new antimitotic bicyclic peptides from the seeds of Celosia argentea. J. Org. Chem., 66, 6626-6633.
100. Yuen, A.K.L., Jolliffe, K.A. and Hutton, C.A. (2006) Preparation of the central tryptophan moiety of the celogentin/moroidin family of anti -mitotic cyclic peptides. Aust. J. Chem., 59, 819-826
101. Michaux, J., Retailleau, P. and Campagne, J.-M. (2008) Synthesis of the central tryptophan-leucine residue of celogentin C. Synlett, 1532-1536.
102. Ma, B., Banerjee, B., Litvinor, D.N., He, L. and Castle, S.L. (2010) Total synthesis of the antimitotic bicyclic peptide celogentin C. J. Am. Chem. Soc., 132, 1159-1171.
103. For Knoevenagel condensation: Zhang, Y., Wada, T. and Sasabe, H. (1996) Synthesis of a new carbazole cyclic dimer via knoevenagel condensation. Tetrahedron Lett., 37, 5909-5912
104. Chrétien, F., Khaldi, M. and Chapleur, Y. (1997) A unified strategy for the synthesis of enantiomerically pure branched-chain cyclohexenones and cyclopentenones from a single progenitor. Tetrahedron Lett., 38, 5977-5980
105. Srikanth, G.S.C. and Castle, S.L. (2004) Synthesis of β-substituted α-amino acids via Lewis acid promoted radical conjugate additions to α, β-unsaturated α-nitro esters and amides. Org. Lett., 6, 449-452
106. Fornicola, R., Oblinger, E. and Montgomery, J. (1998) New synthesis of α-amino acid derivatives employing methyl nitroacetate as a versatile glycine template. J. Org. Chem., 63, 3528-3529
107. For radical conjugate addition see: Srikanth, G.S.C. and Castle, S.L. (2005) Advances in radical conjugate additions. Tetrahedron, 61, 10377-10441
108. For nitro reduction see: (f) Kende, A.S. and Mendoza, J.S. (1991) Controlled reduction of nitroalkanes to alkyl hydroxylamines or amines by samarium diiodide. Tetrahedron Lett., 32, 1699-1702
109. Sturgess, M.A. and Yarberry, D.J. (1993) Rapid stereoselective reduction of thermally labile 2-aminonitroalkanes. Tetrahedron Lett., 34, 4743-4746
110. Larock, R.C. and Yum, E.K. (1991) Synthesis of indoles via palladium -catalyzed heteroannulation of internal alkynes. J. Am. Chem. Soc., 113, 6689-6690
111. Larock, R.C., Yum, E.K. and Refvik, M.D. (1998) Synthesis of 2,3-disubstituted indoles via palladium -catalyzed annulation of internal alkynes. J. Org. Chem., 63, 7652-7662.
112. Braslau, R., erson, M.O., Rivera, F., Jimerez, A., Haddad, T. and Axon, J.R. (2002) Acyl hydrazines as precursors to acyl radicals. Tetrahedron, 58, 5513-5523.
113. Manjunatha, S.G., Chittori, P. and Rajappa, S. (1991) Nitroacetyl group as a peptide synthon: synthesis of Dipeptides with an α, α-bisallylglycine residue at the N-terminus. Helv. Chim. Acta, 74, 1071-1080
114. Manjunatha, S.G., Reddy, K.V. and Rajappa, S. (1990) Nitroketene -S,N-acetals as precursors for nitroacetamides and the elusive nitrothioacetahides. Tetrahedron Lett., 31, 1327-1330.
115. Kaneko, I., Kamoshida, K. and Takahashi, S. (1989) Complestatin, a potent anti-complement substance produced by Streptomyces lavendulae. I. Fermentation, isolation and biological characterization. J. Antibiot., 42, 236-241
116. Kaneko, I., Fearon, D.T. and Ausfen, K.F. (1980) Inhibition of the alternative pathway of human complement in vitro by a natural microbial product, complestatin. J. Immunol., 124, 1194-1198.
117. Seto, H., Fujioka, T., Furihana, K., Kaneko, I. and Takahashi, S. (1989) Structure of complestatin, a very strong inhibitor of protease activity of complement in the human complement system. Tetrahedron Lett., 30, 4987-4990.
118. Momota, K., Kaneko, I., Kimura, S., Mitamura, K. and Shimada, K. (1991) Inhibition of human immunodeficiency virus type-1-induced syncytium formation and cytopathicity by complestatin. Biochem. Biophys. Res. Commun., 179, 243-250.
119. Garfunkle, J., Kimball, F.S., Trzupek, J.D., Takizawa, S., Shimamura, H., Tomishima, M. and Boger, D.L. (2009) Total synthesis of chloropeptin II (complestatin) and chloropeptin I. J. Am. Chem. Soc., 131, 16036-16038.
120. Miyaura, N. and Suzuki, A. (1995) Palladium-catalyzed cross-coupling reactions of organoboron compounds. Chem. Rev., 95, 2457-2483.
121. Searle, P.A. and Molinski, T.F. (1995) Phorboxazoles A and B: potent cytostatic macrolides from marine sponge Phorbas species. J. Am. Chem. Soc., 117, 8126-8131
122. Searle, P.A., Molinski, T.F., Brzezinski, L.J. and Leahy, J.W. (1996) Absolute configuration of phorboxazole A and B from the marine sponge Phorbas sp. 1. Macrolide and hemiketal rings. J. Am. Chem. Soc., 118, 9422-9423
123. Molinski, T.F. (1996) Absolute configuration of phorboxazoles A and B from the marine sponge, Phorbas sp. 2. C43 and complete stereochemistry. Tetrahedron Lett., 37, 7879-7880
124. Capon, R.J., Skene, C., Liu, E.H., Lacey, E., Gill, J.H., Heiland, K. and Friedel, T. (2004) Esmodil: an acetylcholine mimetic resurfaces in a southern australian marine sponge Raspailia (raspailia) sp. Nat. Prod. Res., 18, 305-309.
125. Smith, A.B., Razler, T.M., Ciavarri, J.P., Hirose, T., Ishikawa, T. and Meis, R.M. (2008) A second-generation total synthesis of (+)-phorboxazole A. J. Org. Chem., 73, 1192-1200.
126. Lucas, B.S., Gopalsamuthiram, V. and Burke, S.D. (2007) Total synthesis of phorboxazole B. Angew. Chem. Int. Ed., 46, 769-772
127. Li, D.-R., Zhang, D.-H., Sun, C.-Y., Zhang, J.-W., Yang, L., Chen, J., Liu, B., Su, C., Zhou, W.-S. and Lin, G.-Q. (2006) Total synthesis of phorboxazole B. Chem. Eur. J., 12, 1185-1204
128. Evans, D.A., Fitch, D.M., Smith, T.E. and Cee, V.J. (2000) Application of complex aldol reactions to the total synthesis of phorboxazole B. J. Am. Chem. Soc., 122, 10033-10046
129. Evans, D.A. and Fitch, D.M. (2000) Asymmetric synthesis of phorboxazole B, Part II: synthesis of the C1-C19 subunit and fragment assembly. Angew. Chem. Int. Ed., 39, 2536-2540
130. Lucas, B.S., Luther, L.M. and Burke, S.D. (2004) Synthesis of the C1 - C17 segment of phorboxazole B. Org. Lett., 6, 2965-2968
131. Paterson, I., Steven, A. and Luckhurst, C.A. (2004) Phorboxazole B synthetic studies: construction of C(1-32) and C(33-46) subtargets. Org. Biomol. Chem., 2, 3026-3038
132. Greer, P.B. and Donaldson, W.A. (2002) Synthetic studies directed toward the phorboxazoles: preparation of the C3-C15 bisoxane segment and two stereoisomers. Tetrahedron, 58, 6009-6018.
133. Williams, D.R., Kiryanor, A.A., Emde, U., Clark, M.P., Berliner, M.A. and Reeves, J.T. (2004) Studies of stereocontrolled allylation reactions for the total synthesis of phorboxazole A. Prod. Natl. Acad. Sci. U.S.A., 101, 12058-12063.
134. Jansen, R., Wray, V., Irschik, H., Reichenbach, H. and Hofle, G. (1985) Isolation and spectroscopic structure elucidation of sorangicin a, a new type of macrolide-polyether antibiotic from gliding bacteria-XXX. Tetrahedron Lett., 26, 6031-6034.
135. Irschik, H., Jansen, R., Gerth, K., Hofle, G. and Reichenbach, H. (1987) Sorangicins, novel and powerful inhibitors of eubacterial rna polymerase isolated from myxobacteria. J. Antibiot., 40, 7-13
136. Campbell, E.A., Pavlova, O., Zenkin, N., Leon, F., Irschik, H., Jansen, R., Severinov, K. and Darst, S.A. (2005) Structural, functional, and genetic analysis of sorangicin inhibition of bacterial RNA polymerase. EMBO J., 24, 674-682. And references cited therein.
137. Smith, A.B., III, Dong, S., Brenneman, J.B. and Fox, R.J. (2009) Total synthesis of (+)-sorangicin A. J. Am. Chem. Soc., 131, 12109-12111.
138. Bode, H.B. and Zeeck, A. (2000) Structure and biosynthesis of kendomycin, a carbocyclic ansa -compound from Streptomyces. J. Chem. Soc., Perkin Trans. 1, 323-328
139. Bode, H.B. and Zeeck, A. (2000) Biosynthesis of kendomycin: origin of the oxygen atoms and further investigations. J. Chem. Soc. Perkin Trans. 1, 2665-2670.
140. Smith, A.B., III, Mesaros, E.F. and Meyer, E.A. (2006) Evolution of a total synthesis of (-)-kendomycin exploiting a petasis-ferrier rearrangement/ring-closing olefin metathesis strategy. J. Am. Chem. Soc., 128, 5292-5299.
141. Pettit, G.R. (1991) No. 57, The bryostatins, in Progress in the Chemistry of Organic Natural Products (eds W. Herz, G.W. Kirby, W. Steglich and C. Tamm), Springer-Verlag, New York, USA, pp. 153-195.
142. Blanchette Rockefeller NeuroSciences Institute (2008) Safety, efficacy, pharmacokinetics, and pharmacodynamics study of bryostatin 1 in patients with Alzheimer's disease. http://clinicaltrials.gov (accessed 11 January 2011).
143. Pettit, G.R., Gao, F., Blumberg, P.M., Herald, C.L., Coll, J.C., Kamano, Y., Lewin, N.E., Schmidt, J.M. and Chapuis, J.-C. (1996) Antineoplastic agents. 340. Isolation, structural elucidation of bryostatins 16-18. J. Nat. Prod., 59, 286-289.
144. Trost, B.M. and Dong, G. (2008) Total synthesis of bryostatin 16 using atom-economical, chemoselective approaches. Nature, 456/27, 485-488.
145. Minami, Y., Yoshida, K., Azuma, R., Nishii, M., Inagaki, J. and Nohara, F. (1992) Structure of a novel macrodiolide antibiotic IKD-8344. Tetrahedron Lett., 33, 7373-7376
146. Ishida, T., In, Y., Nishii, M. and Minami, Y. (1994) Stereochemistry of a novel macrodiolide antibiotic IKD-8344. Chem. Lett., 1321-1322
147. Hwang, E.I., Yun, B.S., Yeo, W.H., Lee, S.H., Moon, J.S., Kim, Y.K., Lim, S.J. and Kim, S.U. (2005) Compound IKD-8344, a selective growth inhibitor against the mycelial form of Candida albicans, isolated from Streptomyces sp. A6792. J. Microbiol. Biotechnol., 15, 909-912.
148. Kim, W.H., Hong, S.K., Lim, S.M., Ju M.-A., Jung S.K., Kim, Y.W., Jung, J.H., Kwon, M.S. and Lee E. (2006) Total synthesis of IKD-8344. Angew. Chem. Int. Ed., 45, 7072-7075.
149. Dorta, E., Diaz-Marrero A.R., Brito I., Cueto M., D'Croz L. and Darias J. (2007) The oxidation profile at C-18 of furanocembranolides may provide a taxonomical marker for several genera of octocorals. Tetrahedron, 63, 9057-9062.
150. Donohoe, T.J., Ironmonger, A. and Kershaw, N.M. (2008) Synthesis of (-)-(Z)-deoxypukalide. Angew. Chem. Int. Ed., 47, 7314-7316.
151. Uemura, D., Takahashi, K., Yamamoto, T., Katayama, C., Tanaka, J., Okumura, Y. and Hirata, Y. (1985) Norhalichondrin A: an antitumor polyether macrolide from a marine sponge. J. Am. Chem. Soc., 107, 4796-4798
152. Hirata, Y. and Uemura, D. (1986) Halichondrins-antitumor polyether macrolides from a marine sponge. Pure Appl. Chem., 58, 701-710
153. Pettit, G.R., Tan, R., Gao, F., Williams, M.D., Doubek, D.L., Boyd, M.R., Schmidt, J.M., Chapuis, J.C. and Hamel, E. (1993) Isolation and structure of halistatin 1 from the Eastern Indian ocean marine sponge Phakellia carteri. J. Org. Chem., 58, 2538-2543
154. Litaudon, M., Hickford, S.J.H., Lill, R.E., Lake, R.J., Blunt, J.W. and Munro, M.H.G. (1997) Antitumor polyether macrolides: new and hemisynthetic halichondrins from the New Zealand deep-water sponge Lissodendoryx sp. J. Org. Chem., 62, 1868-1871.
155. Yu, M.J., Kishi, Y. and Littlefield, B.A. (2005) Anticancer Agents from Natural Products (eds G.M. Cragg, D.G.I. Kingston and D.J. Newman), CRC, Boca Raton, FL, USA
156. Newman, S. (2007) Eribulin, a simplified ketone analog of the tubulin inhibitor halichondrin B, for the potential treatment of cancer. Curr. Opin. Invest. Drugs, 8, 1057-1066.
157. Jackson, K.L., Henderson, J.A., Motoyoshi, H. and Phillips, A.J. (2009) A total synthesis of norhalichondrin B. Angew. Chem. Int. Ed., 48, 2346-2350.
158. Miller, E.D., Kauffman, C.A., Jensen, P.R. and Fenical, W. (2007) Piperazimycins: cytotoxic hexadepsipeptides from a marine-derived bacterium of the genus Streptomyces. J. Org. Chem., 72, 323-330.
159. Li, W., Gan, J. and Ma, D. (2009) Total synthesis of piperazimycin A: a cytotoxic cyclic hexadepsipeptide. Angew. Chem. Int. Ed., 48, 8891-8895.
160. Maehr, H., Liu, C., Palleroni, N.J., Smallheer, J., Todaro, L., Williams, T.H. and Blount, J.F. (1986) Microbial products VIII. Azinothricin, a novel hexadepsipeptide antibiotic. J. Antibiot., 39, 17-25.
161. Maskey, R.P., Fotso, S., Sevvana, M., Uson, I., Grun-Wollny, I. and Laatsch, H. (2006) Kettapeptin: isolation, structure elucidation and activity of a new hexadepsipeptide antibiotic from a terrestrial Streptomyces sp. J. Antibiot., 59, 309-314.
162. Hale, K.J., Manaviazar, S., George, J.H., Walters, M.A. and Dalby, S.M. (2009) Total synthesis of (+)-azinothricin and (+)-kettapeptin. Org. Lett., 11, 733-736 and references cited therein.
163. Hale, K.J. and Cai, J. (1997) Asymmetric total synthesis of antitumour antibiotic A83586C. Chem. Commun., 2319-2320
164. Hale, K.J. and Cai, J. (1996) Synthetic studies on the azinothricin family of antitumour antibiotics. 5. Asymmetric synthesis of two activated esters for the northern sector of A83586C. Tetrahedron Lett., 37, 4233-4236.
165. Hale, K.J., Manaviazar, S., Lazarides, L., George, J., Walters, M.A., Cai, J., Delisser, V.M., Bhatia, G.S., Peak, S.A., Dalby, S.M., Lefranc, A., Chen, Y.-N.P., Wood, A.W., Crowe, P., Erwin, P. and El-Tanani, M. (2009) Synthesis of A83586C analogs with potent anticancer and β-catenin/tcf4/osteopontin inhibitory effects and insights into how A83586C modulates E2Fs and pRb. Org. Lett., 11, 737-740.
166. Kobayashi, J., Watanabe, D., Kawasaki, N. and Tsuda, M. (1997) Nakadomarin A, a novel hexacyclic manzamine-related alkaloid from Amphimedon sponge. J. Org. Chem., 62, 9236-9239
167. Kobayashi, J., Tsuda, M. and Ishibashi, M. (1999) Bioactive products from marine micro -and macro-organisms. Pure Appl. Chem., 71, 1123-1126.
168. Ono, K., Nakagawa, M. and Nishida, A. (2004) Asymmetric total synthesis of (-)-nakadomarin A. Angew. Chem. Int. Ed., 43, 2020-2023
169. Jakubec, P., Cockfield, D.M. and Dixon, D.J. (2009) Total synthesis of (-)-nakadomarin A. J. Am. Chem. Soc., 131, 16632-16633.
170. Ye, J., Dixon, J.D. and Hyres, P.S. (2005) Highly enantioselective Michael addition of malonate esters to nitro olefins using a cinchonine-derived bifunctional organic catalyst. Chem. Commun., 4481-4483
171. McCooey, S.H. and Connon, S.J. (2005) Urea-and thiourea-substituted cinchona alkaloid derivatives as highly efficient bifunctional organocatalysts for the asymmetric addition of malonate to nitroalkenes: inversion of configuration at C9 dramatically improves catalyst performance. A ngew. Chem. Int. Ed., 44, 6367-6370
172. Okina, T., Hoashi, Y. and Takemoto, Y. (2003) Enantioselective michael reaction of nalonates to nitroolefins catalyzed by bifunctional organocatalysts. J. Am. Chem. Soc., 125, 12672-12673
173. Jakubec, P., Halliwell, M. and Dixon, D.J. (2008) Cyclic imine nitro-mannich/lactamization cascades: a direct stereoselective synthesis of multicyclic piperidinone derivatives. Org. Lett., 10, 4267-4270.